(firstQuint)Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition.

 The study was an single dose, two-way, crossover, oral bioequivalence study of Lamotrigine tablets 200 mg of Dr.

 Reddy's Laboratories Limited, India comparing with that of LAMICTAL(R) tablets 200 mg of GlaxoSmithKline Inc, in healthy, adult, human subjects under fed condition.

 20 subjects (14 male and 6 womens) are enrolled and completed the study.

 The washout period is 14 days between the two periods of the study.

.

 Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition@highlight

This is an single dose,two-way, crossover, oral bioequivalence study.

